Objective: The incidence of urinary bladder disturbances and renal structural changes and functional decline are found to increase with age. Methods: We investigated the effect of melatonin treatment in addition to estrogen replacement therapy in pinealectomized (Px) and ovariectomized (Ovx) rats. 56 female Wistar rats were divided into seven groups, each containing eight animals: Sham, (Ovx), (Px), Px+Ovx, Px+Ovx receiving estrogen (Px+Ovx+E), Px+Ovx receiving melatonin (Px+Ovx+M) and Px+Ovx estrogen and melatonin supplemented (Px+Ovx+EM) group (EM group). We evaluated reduced glutathione (GSH) levels and malondialdehyde (MDA) levels. The mean collagen fi ber (CF)/smooth muscle (SM) ratio in the bladder wall and structure of the kidney were examined histolologically. We aleso recorded response of the bladder contractility to acetylcholine (Ach). Results: Px and Ovx groups showed statistically signifi cant reductions of antioxidant defenses, impaired Achevoked contraction, histological changes compared with the control group. Also, these changes were prominent in Px+Ovx group compared with all other groups. Both estrogen and melatonin reversed these changes however best restoration was observed in the EM group. Conclusions: Px performed in addition to Ovx led to a distinct increase in oxidative damage in bladder and renal tissue and deteriorate of the detrussor function. Either estradiol or melatonin replacement alone or in combination prevents signifi cant alterations of tissue histology and bladder contractility following Ovx and Px. Thus, combination treatment appears to be the best method to restore both contractility and histomorphology of bladder and kidney tissues after Ovx and Px (Tab. 3, Fig. 4, Ref. 44). Text in PDF www.elis.sk.
Menopausal period induces some hormonal changes in the female organism. These alterations are responsible for many illnesses such as climacteric symptoms, urine incontinence, connective tissue lesions, postmenopausal osteopenia and osteoporosis. All these changes negatively infl uence the quality of life of women (1) . Also , in elderly people, the pineal gland wrinkles and loses its melatonin synthesis ability. This situation may cause damage in the kidney which is one of the better perfused organs. The mechanism(s) underlying renal failure during aging is thought to be sophisticated and related to hypoperfusion, loss of pulsatile perfusion, accumulation of free radicals, and a systemic infl ammatory response (2) . As a result, both, estrogen defi ciency and decrease in the synthesis of melatonin are observed in menopausal period.
Urinary bladder disturbances are frequent in the elderly population who often complain of urgency, frequency, nocturia, and incontinence however the responsible mechanisms are poorly understood (3) . Human and animal studies have shown that estrogen receptors are located throughout the bladder and urethra (4) . Thus, the urogenital tract is sensitive to the effect of estrogenduring adult life. Epidemiological studies have implicated estrogen defi ciency plays a major role in bladder dysfunctions which include urethral and pelvic fl oor muscle weakness, urgency, frequency and underactive detrussor in the postmenopausal women (5) . Also, recent studies suggested that melatonin could restore the age-induced changes in bladder neuromuscular function (6) . It has been reported that melatonin restores the contractile response to cholinergic stimulation in the infl amed bladder (3) .
In the free radical theory of aging, it is suggested that accumulated free radical damage may be responsible for the degenerative process during aging. It is known that there is a reduction of serum melatonin wit aging. The age-related loss of renal parenchyma approximates 10 % per decade of increasing age (7) . This loss is accompanied by a decrease in renal plasma fl ow (8) (9) (10) (11) and tubular dysfunction (12) . Also, the autopsy studies in apparently healthy aging individuals show that aging lead to an increase in globally sclerotic glomeruli, a progressive loss of glomeruli (13) . According to our knowledge, there is no previous study revealing effect of estrogen and melatonin on the renal structural changes in aging animals.
The aim of the present study was to expose rats to one aspect of the ageing process via surgical pinealectomy (Px) and ovariectomy (Ovx) and evaluate the effect of melatonin and estrogen replacement on detrusor myogenic contractile responses in Ovx and Px rat model through the identifi cation of histochemical alterations of the bladder and kidney tissue.
Material and methods

Experimental groups
Fifty-six female Wistar rats weighing 150-200 g were kept at a constant temperature (21 ± 2 ºC) and humidity (60 ± 5 %) in acontrolled room in which a 12:12 h light-dark cycle was maintained.
The rats were divided into seven groups of eight animals each by simple randomization methods as follows: 1) Sham-operated 2) Px 3) Bilateral Ovx 4) Ovx+Px 5) Ovx+Px+Melatonin (M) 6) Ovx+Px+estrogen (E) 7) Ovx+Px+EM. Rats with Px, Ovx or Ovx+Px were housed for 5 months before the beginning of treatment. Melatonin (Sigma Chemical Co., St Louis, MO, USA) was dissolved in ethanol and further diluted in saline (vehicle) (0.09 % NaCl, w/v) to give a fi nal concentration of 1 %. Melatonin-treated animals were injected with 5 mg/kg melatonin (i.p.) for 28 days. All injections were administered at 17:00 h. Estro gen-treated animals received subcutaneous injections of 250 μg/kg β-estradiol 17-cypionate (Sigma) in corn oil once a week for 4 weeks. Animals from sham-operated and Ovx+Px group received an equal volume (0.5 mL/kg) of vehicle solution.
The experiment was performed in accordance with the Guidelines for Animal Research from the National Institute of Health and was approved by the Committee on Animal Research at Inonu University, Malatya.
For experimental Px and Ovx in the same season, the rats were preoperatively anesthetized with a mixture of ketamine hydrochloride (75 mg/kg) and xylazine hydrochloride (8 mg/kg) intraperitoneally (i.p.). According to anatomic localization of pineal gland and ovaries, the skin was shaved with electric clippers and prepared with povidone-iodine (Poviiodeks;Kim-Pa Ilac Lab. Tic. Ltd. Sti., Istanbul, Turkey). During the surgical procedure asepsis was maintained with a local sterile environment.
Pinealectomy
Pinealectomy was performed as described by Hoffman and Reiter (14) . The skin on the top of the head was cut to expose the skull. The animal was fastened to the dissection table; an incision was made in the skin and the subcutaneous tissue, bringing the lambda into view. The skullcap was opened with the aid of a micromotor, bringing the cerebral hemispheres and the superior sagittal sinus into view. The pineal gland , located under the venous sinus, was removed in one piece using forceps. Next, the bone fragment was returned to its place and the surgical layers were sutured. After surgery, the animals received a single dose of prophylactic antibiotic. The procedure was completed within 15 min. Pinealectomy was confi rmed by the histological evaluation of the gland for each animal. Rats in the sham-operated group underwent similar surgical procedures without the removal of the pineal gland.
Ovariectomy
It was performed bilateraly under the anesthesia 4 cm midline laparotomy was made through the fl ank skin of the rat, and the ovaries and ovarian fat were removed. Ovaries were isolated by ligation of the most proximal portion of the oviduct before removal (15) . Immediately after surgery, 5 mg/kg of carprofen was injected subcutaneously for analgesia.
Preparation of rat urinary bladder strips
After the last injection the bladders were obtained from all rats. Each bladder was divided into 2 pieces. The fi rst sample was used for histopathological examination. We immediately placed the second sample in an isolated organ bath fi lled with Krebs-H enseleit solution containing (in mmol/L): NaCl 118, KCl 4.8, CaCl 2 25 , and glucose 10; 37 °C, pH 7.4) and continuously bubbled with a mixture of 95 % O 2 and 5 % CO 2 . The lower end of the strip was fi xed to a metal hook and the upper end attached to an isometric force-displacement transducer (BIOPAC Systems, Inc). All strips (2×10 mm) were allowed to equilibrate under a resting tension of 1 g for 60 min (the bath fl uid was changed every 15 min with fresh Krebs solution). After this period, all preparations were contracted with 10 mM acetylcholine (ACh). We quantifi ed the contractility patterns in all groups by changes in mean amplitude (g).
Biochemical determination
The tissue samples were stored at -80 °C for the determination of malondialdehyde (MDA) and total glutathione (GSH). The tissue specimens were homogenized (PCV Kinematica Status Homogenizator) in ice-cold phosphate buffered saline (pH 7.4). The homogenate was sonifi ed with an ultrasonifi er (Bronson sonifi er 450) by three cycles (20-s sonications and 40-s pause on ice). The homogenate was centrifuged (15 000 g, 10 min, 4 °C), and cell-free supernatant was subjected to enzyme assay immediately.
The level of GSH was determinedusing the method of Theodorus et al. with some modifi cations (16) . The reaction mixture contained 50 mM sodium phosphate, 1 mM EDTA, 0.5 mM DTNB, 0.2 mM NADPH, and 0.5 U/mL of glutathione reductase. Homogenate (10 lL) was added to initiate the reaction but was omitted for control. The formation of 5-thio-2-nitrobenzoate is followed spectrophotometrically at 412 nm. The amount of GSH in the extract was determined as nmol/mg protein utilizing a commercial GSH as the standard.
The analysis of MDA was carried out as described by Buege et al (17) with a minor modifi cation. The reaction mixture was prepared by adding 250 mL homogenate into 2 mL reaction solution (15 % trichloroacetic acid: 0.375 % thiobarbituric acid: 0.25 N HCl, 1:1:1, w/v) and heated at 100 °C for 15 min. The mixture was cooled to room temperature, centrifuged (10 000 g for 10 min), and the absorbance of the supernatant was recorded at 532 nm. 1,1,3,3-Tetramethoxypropane was used as MDA standard. MDA results were expressed as nmol per mg protein in the homogenate.
Histological evaluations
The tissues were fi xed in 10 % formalin for approximately 24 h and embedded in paraffi n blocks. The tissue blocks were cut into 4 μm sections. The sections were stained with hematoxylin-eosin for urinary bladder epithelium and general structure of the kidney. Masson's trichrome stain was used for demonstrating the collagen and muscle in the urinary bladder. The collagen was stained green and muscle was stained as red with Masson's trichrome. The areas that were stained red and green were measured using Leica Q Win software image analysis system (Leica Micros Imaging Solutions Ltd, Cambridge, UK) on slides. Morphometric assays were made in ten different fi elds for each section. The average area for CF and SM and CF/SM ratio were calculated for each group.
The kidneys we re examined for the presence of tubular injury and interstitial changes by an experienced observer unaware of the animal treatment groups. The tubular injury was defi ned as tubular desquamation and tubular epithelial cell swelling. The following semiquantitative score was used: score 0 = no tubular injury, score 1 = < 10 % of tubules were injured, score 2 = 10-25 % of the tubules were injured, score 3 = 25-50 % of the tubules were injured, score 4 = 50-75 % tubules injured and score 5 = > 75 % of tubules were injured. The tubulointersti tial area was evaluated as infl ammatory cell infi ltration, haemorrhagia and congestion. The interstitial changes were graded from 0 to 4 (0 = no changes; 1 = changes affecting less than 25 % of the samples; 2 = changes affecting 25-50 % of the samples; 3 = changes affecting 50-75 % of the samples; 4 = changes affecting more than 75 % of the samples). For each specimen 10 microscopic fi elds were analyzed under a 20X objective per animals (18) .
Statistical analysis
The results ar e given as mean±standard error (S.E) in the text. Normality of the distribution was confi rmed using the Kolmogorov-Smirnov Z-test. The homogeneity of variance assumption was examined using Levene's test. Where differences among the groups were detected, group means were compared using the Mann-Whitney U test. Values of p<0.0 5 were considered significant. The differences were considered signifi cant when P < 0.05. Statistical analyses were performed using The Statistical Package for Social Sciences (SPSS, Chicago, IL, USA) (Ver.17.0). Table 1 shows the mean amplitudes of contractility measurements in all groups in response to 100 μmol/l Ach. The isolated bladder strips revealed signifi cantly decreased bladder contractility in the groups of Px ,Ovx, Px+Ovx compared with the sham-operated rats (p <0.05). This fi nding was prominent in Px+Ovx group. Also, both exogenous melatonin and estrogen treatments tended to reverse this effect (p <0.05). We further evaluated the combined usage of estrogen and melatonin on ACh-induced contractions of bladder strips. The combination of melatonin and estrogen treatment was more effi cient on bladder contractile response than single application of either estrogen or melatonin.
Results
Bladder contractile responses
Biochemical results
The mean level of MDA, which is a major degradation product of lipid peroxidation, in bladder and kidney samples showed a marked increase following Px and Ovx compared with the sham group (p < 0.005). It was seen that the highest levels of MDA were in Px+Ovx groups (p < 0.005). On the other hand, estrogen and melatonin treatment in the Px+Ovx group reduced MDA levels (p < 0.005). The combination treatment was more effi cient in reducing MDA levels than a single administration ( Figs 1A, 1B) .
The GSH values of all groups are shown in Figures 2A 
Tab. 1. Mean urinary bladder contractile responses of the groups (Mean values ± SE).
Fig. 1. MDA level in bladder (A) and kidney (B) tissues.
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GSH levels, whereas, melatonin and estrogen administration signifi cantly reduced these values (p < 0.005). It was seen that the highest levels were found in Px+Ovx+M+E group and lowest levels were found in Px+Ovx (p < 0.005).
Histological results
Bladder
Mean collagen fi ber (CF)/smooth muscle (SM) ratio ranged from low (control, 0.98 ± 0.1) to moderate (Px-Ovx+M, 1.04 ± 0.1 and Px-Ovx+EM, 1.04 ± 0.1) and to high (Px, 1.15 ± 0.1; Ovx, 1.15 ± 0.1; Px-Ovx+E, 1.15 ± 0.2 and, Px-Ovx, 1.21 ± 0.0). The ratio for the Px-Ovx group was higher than in the sham group (p = 0.009). On the other hand, the CF/SM ratio was similar to each other in sham and Px-Ovx+EM groups. There was no signifi cant difference between the ratios of the Px-Ovx group and the PxOvx+E group (p > 0.05). Also there was no signifi cant difference between the ratios of the group Px-Ovx+M and Px-Ovx+EM group (p > 0.05). The mean collagen fi ber, smooth muscle and CF/SM ratio are given i n Table 2 .
The control group exhibited normal stratifi ed transitional urinary bladder epithelium with H&E staining method (Fig. 3A) . In the Px, Ovx and Px-Ovx+E groups, the number of layers of stratifi ed transitional urinary bladder epithelium was decreased ( Figs 3B, C and D) . There was also desquamation of the lining of epithelial cells and loss of urothelial cells in Px-Ovx group. Exfoliated urothelial cells were detected in the lumen of the urinary bladder in this group (Fig. 3E) . In the Px-Ovx+M and Px-Ovx+EM groups, although the urothelium preserved almost its normal appearance, some areas showed local epithelial desquamation and 
Tab. 2. Mean CF, SM, and CF/ SM values of the groups (Mean values ± SE).
Fig. 3. Control group (A); normal histological appearance of urinary bladder epithelium (arrows). Px group (B); there is a prominent reduction in the number of layers of stratifi ed transitional urinary bladder epithelium (arrows). Ovx group (C); appearance of the urinary bladder epithelium (arrows). Px-Ovx+E group (D); view of epithelium (arrows) is similar to
Kidney
The sham group revealed normal kidney parenchyma (Figure not shown). The morphological damage was marked in tubulointerstitial area rather than tubules in the treatment groups. Degenerative changes in the interstitial area were moderate in the Px and Ovx groups. The histological fi ndings of these two groups were close to each other ( Figs 4A and 4B) . The Px-Ovx group showed extreme interstitial damage such as interstitial congestion, hemorrhage and infl ammatory cell infi ltration (Fig. 4C) . The damage in the interstitial area was observed as decreased in Px-Ovx+E and PxOvx+M groups and it was not as extensive as in the Px-Ovx group (Figs 4D and 4E ). Infl ammatory cell infi ltration and congestion were limited in these groups. Px-Ovx+EM group was also similar to Px-Ovx+M group (Fig. 4F) . The most obvious tubulointerstitial damage occurred in the Px-Ovx group (4.0 ± 0.6) followed by the Px and Ovx (2.5 ± 0.5 and 2.3 ± 0.5) then Px-Ovx+E, (1.3 ± 0.5) PxOvx+M (1.16 ± 0.4) and lastly in Px-Ovx+EM (1.16 ± 04) groups. Slight tubular desquamation was present in all groups (Tab. 3).
Discussion
Ovx rats have been used as a model of menopause induced estrogen defi ciency in humans (3). Iit has long been documented that both ratios of calcifi ed pineal gland and the density of pineal calcifi cation increased progressively with aging. Decreases of the total antioxidant capacity of human serum with age nearly correlate with its melatonin concentration (19) . Advancing age leads to some changes in the structure and functions of the bladder and kidney tissue (20) . The results of the present study indicate that Px and Ovx increase MDA levels whereas they decrease the GSH levels and urinary bladder contractile response. Also, a signifi cant structural damage in the bladder and kidney tissue was determined. These fi ndings are most prono unced in Ovx +Px group. Both estrogen and melatonin treatment reduced the morphological damage and repaired the detrusor function. However, the combined therapy of estrogen and melatonin was signifi cantly more effective than when estrogen or melatonon were applied alone.
Decreases in estrogen concent ration associated with menopause have been considered as a factor responsible for increasing the urinary incontinence prevalence in aging women (21) . Sex hormones are known to have an important infl uence on the function of the lower urinary tract throughout adult life (5). Thus, hormone replacement is used i n postmenopausal women with lower urinary tract dysfunction (22) . Several factors such as neuronal innervation, structure of organs and the contractile response of the smooth muscle elements may affect the bladder function. These factors are closely correlated to each other, and a change in one factor can cause important adaptive changes in the other two. Thus, hormone replacement therapy can considerably affect the bladder function by changing innervations and vascular density and distribution, receptor density and distribution, smooth muscle size and number, and connective tissue density and distribution (23) (24) (25) . There are considerable contradictory da ta on the effect of estrogen administration on bladder function and structure. Rehfuss et al (26) reported that the low estrogen level induced decreased bladder mass, smooth muscle content, contraction, blood fl ow and increased free radical damage. Also, previous studies suggested that Ovx can cause a decreased of blood fl ow around the bladder neck and urethra, mucosal and smooth muscle atrophy, increased collagen synthesis and distribution, and decreased contractility. Estrogen replacement reduced the effects of Ovx and resulted in smooth muscle hypertrophy and enhanced contractility (27) . Also it has been reported that estrogen mediates angiogenesis accounting for the increased vascular density and increased blood fl ow. The effects may be mediated through tissue energy supplies (5) . On the other hand data from the randomized, double-blind, placebo-controlled trials clearly show that hormonal therapy neither imp roves continence nor prevents the development of incontinence in continent individuals. Thus, the authors have not reached a consensus about hormonal therapy for the treatment of incontinence (28, 29) . In our study, we determined that Ovx caused oxidative damage in rats, therefore the level of MDA, a product of lipid peroxidation, is generated as a result of the toxic effects of active oxygen radicals. The levels of GSH which have roles as antioxidants in the organism were decreased signifi cantly after removing estrogen from the body. This parameter increased more as a consequence of Ovx with Px. The results of our study demonstrate that Ovx and Px in rats increased the CF/SM ratio in the bladder wall (p < 0.05). Both estrogen and melatonin treatment decreased this ratio. However melatonin was more effective than estrogen. In vitro studies show that aging affects both the myogenic responses to neurotransmitters and Ca 2+ sensitization mechanisms in smooth muscle (30, 31) . However, considerable contradictory da ta are still present on the effect of estrogen administration on bladder function and structure. There is a signifi cant variation in the reported results. Some studies show age-dependent raises (32, 33) or reduction in ACh-induced responses (34), whereas others report no changes in carbachol stimulated contract ion (35, 36) . Our data showed that Ovx impairs Ach-evoked contractile response and estrogen treatment recovered the detrusor contraction by its effect on the oxidative stress and CF\SM ratio.
Melatonin, the main secretory product of the pineal gland, is known to be a potent free radical scavenger and anti-oxidant. The decrease in total antioxidant capacity of human serum with age nearly correlates with its melatonin concentration (19) . The incidence of urinary bladder disturbances increases with age. Gomez-Pinilla et al showed that a reduction in Ca 2+ sensitization mechanisms which correlates with increased oxidative stress was proposed as a causal factor. Also, they suggested that the melatonin treatment restored the contractile response of bladder smooth muscle through an increase Ca 2+ sensitivity and normalized oxidative stress parameters (3). Onur et al (37) determined that melatonin restored bladder contractility in rabbits with partial outlet obstruction by antioxidant effect. In the present study, we demonstrated that Px induced a reduction of antioxidant defenses including GSH in bladder and kidney tissue. Px was more effi cient than Ovx on MDA and GSH levels (especially in kidney). In addition, Pedro J et al (38) reported that the antioxidant properties of melatonin could ameliorate the alterations of bladder neuromuscular function associated with age. Also, Yasmir Quiroz et al (39) reported that melatonin treatment reduced oxidative stress and infl ammation, decreased the abundance and expression of collagen, transforming growth factor-β, and α-smooth muscle actin, and prevented functional and structural deterioration in the remnant kidney. The results of the present study demonstrated that Px induced a decrease in contractile responses to nerve stimulation and the administration of melatonin attenuates deterioration of detrusor function and structure.
Aging is associated with renal structural changes and functional decline (40). The investigators discovered an age-related nephrosclerosis (41) and a gradual loss of nephron number with aging (42). Nyengaard and Bendtsen (43) showed that the "senile" kidney was characterized by nephron and kidney shrinkage, an increase in globally sclerotic glomeruli. There are a great number of different theories of primarily disease-independent renal aging. Recent evidence has been provided that various pathophysiologic pr essures such as oxidative stress and mitochondrial injury can be induced to aging kidney. It is suggested that en alapril and losartan treatments reduce age-associated renal damage by attenuating the age associated increase in mitochondrial oxidant production (44) . In our study, we explored whether a reduction of melatonin and estrogen levels in the circulation played an important role in the damage to the kidney resulting from aging. We documented that renal MDA levels in Px+Ovx, Px, Ovx rats were higher than in control animals. Morpholological changes including tubular desquamation and tubular epithelial cell swelling, tubulointerstitial haemorrhagia and congestion were clearly observed in the kidney of Px+Ovx rats. However, appearance of glomeruli was normal. The most remarkable repair was in the combination treatment group.
Conclusion
Recent studies suggested that both Ovx and Px have an effect on oxidant and antioxidant systems in bladder and kidney tissues. It is also well known that estrogen defi ciency has an important role on the detrusor function and bladder structure. Thus, in the current study we mainly focused on the effects of melatonin treatment in addition to estrogen replacement therapy in Px and Ovx rats. In conclusion, this study demonstrated that Px deteriorated the bladder function and structure by increasing oxidative stress in Ovx rats. Also, we found a signifi cant impairment in the kidney structure. Estrogen or melatonin supplementation in the Ovx-Px rats reduced the damage by activating the antioxidant systems. However, the combined use of melatonin and estrogen was more effective than single treatment. Finally, the protective effects of both melatonin and estrogen treatments on the renal and bladder structure and functions should also be further investigated.
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